GB201615914D0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB201615914D0 GB201615914D0 GBGB1615914.7A GB201615914A GB201615914D0 GB 201615914 D0 GB201615914 D0 GB 201615914D0 GB 201615914 A GB201615914 A GB 201615914A GB 201615914 D0 GB201615914 D0 GB 201615914D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1615914.7A GB2554091A (en) | 2016-09-19 | 2016-09-19 | Pharmaceutical composition |
ES17777637T ES2877575T3 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition comprising salmeterol |
US16/334,144 US10792256B2 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
JP2019515225A JP6781828B2 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
BR112019005168A BR112019005168A2 (en) | 2016-09-19 | 2017-09-18 | pharmaceutical composition, sealed container, metered dose inhaler, and methods for treating a patient suffering or likely to suffer from a respiratory disorder, for improving the stability of a pharmaceutical composition and the aerosolization performance of a pharmaceutical composition global warming potential of a pharmaceutical composition |
AU2017328910A AU2017328910B2 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
MX2019003099A MX2019003099A (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition. |
CA3037107A CA3037107C (en) | 2016-09-19 | 2017-09-18 | Stable pharmaceutical compositions comprising salmeterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis) |
CN201780057318.5A CN109715148A (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
EP17777637.4A EP3515425B1 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition comprising salmeterol |
PCT/GB2017/052764 WO2018051133A1 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
ZA2019/02051A ZA201902051B (en) | 2016-09-19 | 2019-04-02 | Pharmaceutical composition |
US16/882,979 US11311502B2 (en) | 2016-09-19 | 2020-05-26 | Pharmaceutical composition |
US16/883,016 US11077076B2 (en) | 2016-09-19 | 2020-05-26 | Pharmaceutical composition |
US17/694,972 US11883372B2 (en) | 2016-09-19 | 2022-03-15 | Pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1615914.7A GB2554091A (en) | 2016-09-19 | 2016-09-19 | Pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201615914D0 true GB201615914D0 (en) | 2016-11-02 |
GB2554091A GB2554091A (en) | 2018-03-28 |
Family
ID=57288758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1615914.7A Withdrawn GB2554091A (en) | 2016-09-19 | 2016-09-19 | Pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2554091A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2573297A (en) * | 2018-04-30 | 2019-11-06 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
WO2021151857A1 (en) * | 2020-01-28 | 2021-08-05 | Chiesi Farmaceutici S.P.A. | Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation |
WO2024201526A1 (en) * | 2023-03-28 | 2024-10-03 | Cipla Limited | Pharmaceutical composition of ensifentrine with pharmaceutically acceptable propellants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2259915B1 (en) * | 2005-03-15 | 2007-12-16 | Laboratorio Aldo-Union, S.A. | NEW STABLE FORMULATION OF AEROSOLS IN SUSPENSION AND PROCEDURE OF OBTAINING. |
GB201108039D0 (en) * | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
-
2016
- 2016-09-19 GB GB1615914.7A patent/GB2554091A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2554091A (en) | 2018-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265360B (en) | Pharmaceutical composition | |
IL265260B (en) | Pharmaceutical composition | |
IL271986A (en) | Pharmaceutical composition | |
IL262654A (en) | Pharmaceutical composition | |
IL265349A (en) | Pharmaceutical composition | |
GB201712159D0 (en) | Pharmaceutical composition | |
IL272419A (en) | Pharmaceutical composition | |
PT3583943T (en) | Pharmaceutical composition | |
GB201506526D0 (en) | Medicinal composition | |
IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
GB201521462D0 (en) | Pharmaceutical composition | |
GB201719447D0 (en) | Pharmaceutical composition | |
GB201615917D0 (en) | Pharmaceutical composition | |
EP3727485C0 (en) | Pharmaceutical composition | |
GB201515310D0 (en) | Pharmaceutical composition | |
PL3454838T3 (en) | Pharmaceutical composition | |
GB201615914D0 (en) | Pharmaceutical composition | |
GB201520862D0 (en) | Pharmaceutical composition | |
IL263999A (en) | Pharmaceutical compositions | |
GB201615910D0 (en) | Pharmaceutical composition | |
IL265436B (en) | Pharmaceutical composition | |
ZA201705782B (en) | Pharmaceutical compositions | |
PL3424500T3 (en) | Pharmaceutical composition comprising famitinib | |
GB201620519D0 (en) | Pharmaceutical composition | |
IL265428A (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |